Cencora Price to Free Cash Flow Ratio 2010-2024 | COR

  • Cencora average price to free cash flow ratio for 2024 was 12.54, a 1.87% decline from 2023.
  • Cencora average price to free cash flow ratio for 2023 was 12.31, a 9.15% increase from 2022.
  • Cencora average price to free cash flow ratio for 2022 was 13.55, a 9.89% decline from 2021.

Price to free cash flow ratio can be defined as

Historical Chart (TTM)

Click on chart icon to view chart
Click on table icon to view table

Annual Chart

Click on chart icon to view chart
Click on table icon to view table
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$148.1B
Elevance Health (ELV)$90.8B
CVS Health (CVS)$83.7B
DiDi Global (DIDIY)$23.1B
Natera (NTRA)$22.8B
ICON (ICLR)$15.8B
Doximity (DOCS)$14.3B
BioMerieux (BMXMF)$14.1B
Revvity (RVTY)$14B
Viatris (VTRS)$13B
Solventum (SOLV)$12.8B
Avantor (AVTR)$12B
CochLear (CHEOY)$11.5B
Medpace Holdings (MEDP)$10.5B
HealthEquity (HQY)$9.9B
EUROFINS SCIENT (ERFSF)$9.5B
Sonic Healthcare (SKHHY)$8.8B
Charles River Laboratories (CRL)$8.4B
Amplifon S.p.A (AMFPF)$6.2B
Bausch + Lomb (BLCO)$5.7B
Organon (OGN)$3.9B
Sotera Health (SHC)$3.9B
BrightSpring Health Services (BTSG)$3.6B
Surgery Partners (SGRY)$3.3B
GeneDx Holdings (WGS)$3.1B
Concentras Parent (CON)$3B
Alignment Healthcare (ALHC)$2.7B
Teladoc Health (TDOC)$2.4B
Ardent Health Partners (ARDT)$2.1B
Progyny (PGNY)$2B